your primary care physician will be happy to help you achieve a healthier version of yourself in any way they can
GLP-1 medications are FDA-approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27-29.9) with at least one weight-related comorbidity
So as of May 2026, the Bridge is the only confirmed pathway for Medicare to cover GLP-1s for weight loss
Unapproved products are risky not only because they havent been reviewed by the FDA, but because theres no way to know their potency, possible contamination, or potential dosing errors
However, some studies have claimed no effect on axiogenesis when used acutely 3 in both males and females except a slight increase in anxiety in female rats
Diabetes Care 44(3):765773 Kim WJ, Lee SJ, Lee E, Lee EY, Han K (2022) Risk of incident dementia according to glycemic status and comorbidities of hyperglycemia: a nationwide population-based cohort study